Comparison of the Effects of LY2605541 and Insulin Glargine on Endogenous Glucose Output and Peripheral Glucose Disposal in Healthy Subjects and Patients With Type 1 Diabetes Mellitus
Phase of Trial: Phase I
Latest Information Update: 18 Sep 2015
At a glance
- Drugs Insulin peglispro (Primary) ; Insulin glargine
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Eli Lilly
- 01 Oct 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Sep 2013 Planned end date changed from 1 Sep 2013 to 1 Oct 2013 as reported by ClinicalTrials.gov.
- 09 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.